depression

News

PHTI to review digital hypertension, mental health tools

The Peterson Health Technology Institute (PHTI) has added hypertension and mental health to the list of digital health technologies (DHTs) that it will review for their cl

News

Exercise ‘may be better than drugs for depression’

Doctors should think twice before prescribing drug therapies when faced with someone battling depression, as exercise may be more effective, according to a new study.

News

Alto hits a high note with AI-driven depression therapy

Alto Neuroscience has said its therapeutic approach to depression of matching patients to drugs based on brain biomarkers has shown promise in a phase 2a trial.

News

Cybin preps for ph3 as psychedelic clears depression trial

Cybin has unveiled phase 2 results with its psychedelic medicine for major depressive disorder, which it says support moving the drug into a phase 3 programme.

News

Pilot study finds VR training benefit in depression

People with depression can sometimes have impaired memory, particularly for positive events, which can contribute to cognitive problems and impair their daily lives.

News

Otsuka makes psychedelics play, buying Mindset

Japanese pharma group Otsuka has signed an agreement to acquire Canada's Mindset Pharma, a specialist in psychedelic medicines for neuropsychiatric disorders.

PHTI to review digital hypertension, mental health tools

Exercise ‘may be better than drugs for depression’

Alto hits a high note with AI-driven depression therapy

Cybin preps for ph3 as psychedelic clears depression trial

Pilot study finds VR training benefit in depression

Otsuka makes psychedelics play, buying Mindset

Setback for MSD as German court blocks Keytruda SC launch

How to meet your physicians where they are online

depression

Editor's Picks